Showing results (1821-1830 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 17, 2004
Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patientsSelma Ugurel, Dario Uhlig, Claudia Pföhler, et al.
Cancer Immunology, Immunotherapy : CII|January 20, 2004
MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chainDan Ilkovitch, Suzanne Ostrand-Rosenberg
Cancer Immunology, Immunotherapy : CII|January 24, 2004
Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancerMichael E Gillogly, Nikoletta L Kallinteris, Minzhen Xu, et al.
Cancer Immunology, Immunotherapy : CII|January 24, 2004
Dendritic cells are dysfunctional in patients with operable breast cancerSukchai Satthaporn, Adrian Robins, Wichai Vassanasiri, et al.
Cancer Immunology, Immunotherapy : CII|September 17, 2004
Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancerRamesh K Ramanathan, Kenneth M Lee, John McKolanis, et al.
Cancer Immunology, Immunotherapy : CII|April 20, 2005
New developments in dendritic cell-based vaccinations: RNA translated into clinicsFrank Grünebach, Martin R Müller, Peter Brossart
Cancer Immunology, Immunotherapy : CII|April 20, 2005
Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memoryVolker Schirrmacher
Cancer Immunology, Immunotherapy : CII|March 8, 2005
Induction of specific human primary immune responses to a Semliki Forest virus-based tumor vaccine in a Trimera mouse modelBing Ni, Wenda Gao, Bo Zhu, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2005
Identification of a potential human telomerase reverse transcriptase-derived, HLA-A1-restricted cytotoxic T-lymphocyte epitopeMarco W J Schreurs, Esther W M Kueter, Kirsten B J Scholten, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Induction of interleukin-2 receptor by tumor necrosis factor alpha on cultured ovarian tumor-associated lymphocytesC G Ioannides, B Fisk, B Tomasovic, et al.
Pageof 652